| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q46759895 | Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia |
| Q90129599 | Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study |
| Q39668296 | Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia |
| Q47560023 | Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline |
| Q55436300 | Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline. |
| Q46391737 | Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting |
| Q40327943 | Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers |
| Q35579243 | Predictors of long-term cognitive outcome in Alzheimer's disease |
| Q37237863 | Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage |
| Q51867713 | Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. |
| Q35800785 | Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis |
| Q51758135 | Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. |
| Q51558760 | Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. |
| Q38686461 | The frequency and influence of dementia risk factors in prodromal Alzheimer's disease |
Search more.